our customers, including many of the world’s top multinational companies in the medical device and pharmaceutical sectors, achieve... of NNIT, catering to an established customer base that includes top-tier Pharma and medical device clients. To excel in...
Are you ready to make a global impact in medical affairs? Join LEO Pharma as our new Head of Global Strategic Evidence... Asset Teams, and Global Medical Excellence to optimize data dissemination. Lead the Integrated Evidence Planning process...
? We are looking for a Business Partner Lead to collaborate closely with one of our exceptional diabetes medical teams, as well as the Vice President... Lead, you will be a part of the Business Partner team and allocated to one of the medical teams, working closely...
for employment without regard to age, ancestry, color, family or medical care leave, gender identity or expression, genetic... information, marital status, medical condition, national origin, physical or mental disability, political affiliation, protected...
Illumina's employee benefits are industry-leading and include, flexible time off, private medical insurance, compassion... or ancestry, physical or mental disability, medical condition, sexual orientation, pregnancy, military or veteran status...
applicants will receive consideration for employment without regard to age, ancestry, color, family or medical care leave, gender... identity or expression, genetic information, marital status, medical condition, national origin, physical or mental disability...
Latest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your favourite companies. This blog keeps you informed on all things Dalal Street and global markets. Continue Reading »
With concerns of political and economic stability allayed, the upcoming Union budget and corporate earnings are expected to be the next big triggers for foreign investors in Indian equities Continue Reading »
Spanish bakery firm Europastry SA postponed its initial public offering, becoming the latest European firm to halt listing plans amid the region’s faltering IPO revival. Continue Reading »
The whipsawing of rates in the market for repurchase agreements suggests that the collapse in funding costs seen earlier in the year has come to an end. Continue Reading »